Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2005 3
2006 13
2007 29
2008 57
2009 111
2010 103
2011 104
2012 146
2013 173
2014 138
2015 160
2016 169
2017 146
2018 151
2019 148
2020 153
2021 139
2022 120
2023 97
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

1,858 results

Results by year

Filters applied: . Clear all
Page 1
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.
Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators. Schüpke S, et al. N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475799 Clinical Trial.
Prasugrel-related hepatotoxicity.
Dogan Z, Yurtdas M, Bektasoglu G. Dogan Z, et al. J Pak Med Assoc. 2022 Nov;72(11):2295-2297. doi: 10.47391/JPMA.3179. J Pak Med Assoc. 2022. PMID: 37013306 Free article.
Herzinfarkt: Prasugrel schlägt Ticagrelor.
Radke PW. Radke PW. MMW Fortschr Med. 2019 Nov;161(20):36. doi: 10.1007/s15006-019-1115-2. MMW Fortschr Med. 2019. PMID: 31773609 Review. German. No abstract available.
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
Gimbel M, Qaderdan K, Willemsen L, Hermanides R, Bergmeijer T, de Vrey E, Heestermans T, Tjon Joe Gin M, Waalewijn R, Hofma S, den Hartog F, Jukema W, von Birgelen C, Voskuil M, Kelder J, Deneer V, Ten Berg J. Gimbel M, et al. Lancet. 2020 Apr 25;395(10233):1374-1381. doi: 10.1016/S0140-6736(20)30325-1. Lancet. 2020. PMID: 32334703 Clinical Trial.
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized Trial.
Natsuaki M, Watanabe H, Morimoto T, Yamamoto K, Obayashi Y, Nishikawa R, Ando K, Domei T, Suwa S, Ogita M, Isawa T, Takenaka H, Yamamoto T, Ishikawa T, Hisauchi I, Wakabayashi K, Onishi Y, Hibi K, Kawai K, Yoshida R, Suzuki H, Nakazawa G, Kusuyama T, Morishima I, Ono K, Kimura T. Natsuaki M, et al. Circulation. 2024 Feb 20;149(8):585-600. doi: 10.1161/CIRCULATIONAHA.123.066720. Epub 2023 Nov 23. Circulation. 2024. PMID: 37994553 Clinical Trial.
Pharmacogenetics of P2Y12 receptor inhibitors.
Thomas CD, Williams AK, Lee CR, Cavallari LH. Thomas CD, et al. Pharmacotherapy. 2023 Feb;43(2):158-175. doi: 10.1002/phar.2758. Epub 2023 Jan 13. Pharmacotherapy. 2023. PMID: 36588476 Free PMC article. Review.
1,858 results